Normann T, Gautvik K M, Johannessen J V, Brennhovd I O
Acta Endocrinol (Copenh). 1976 Sep;83(1):71-85. doi: 10.1530/acta.0.0830071.
A study of the clinical, biochemical and histological findings of 57 patients with medullary thyroid carcinoma (MCT) in Norway, is presented. The diagnosis was established by light and electron microscopy and by measurements of immunoreactive calcitonin (iCT) in serum. The major factor influencing the prognosis was the extension of the disease at presentation. None of the 24 patients with tumour confined to the thyroid gland have died of the disease, and serum iCT was normal in 15 patients. Of 19 patients with regional lymph node metastes only 11 are alive 1 to 14 years after treatment, and of these 9 had increased serum iCt. 14 patients technically inoperable and/or with distant metastases, 12 have died of MCT, 1 are alive with elevated serum iCT. Of 14 patients with raised serum iCT, 8 have no clinical recurrence of the disease from 1 to 15 years after the operation. MCT-associated diseases were found in 8 patients, chronic thyroiditis in 10. Serum iCT was measured in 249 relatives of 42 patients, and abnormal elevations were found in 11 members of 6 families.
本文介绍了对挪威57例甲状腺髓样癌(MCT)患者的临床、生化和组织学研究结果。诊断通过光镜和电镜检查以及血清免疫反应性降钙素(iCT)测定来确定。影响预后的主要因素是就诊时疾病的分期。24例肿瘤局限于甲状腺的患者均未死于该病,15例患者血清iCT正常。19例有区域淋巴结转移的患者中,治疗后1至14年仅有11例存活,其中9例血清iCt升高。14例因技术原因无法手术和/或有远处转移的患者中,12例死于MCT,1例存活且血清iCT升高。14例血清iCT升高的患者中,8例术后1至15年无疾病临床复发。8例患者发现有MCT相关疾病,10例有慢性甲状腺炎。对42例患者的249名亲属进行了血清iCT检测,6个家族的11名成员发现异常升高。